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Abstract
Imaging Ductal Carcinoma Using Hyperspectral
Imaging System
Yasser M. Khouj
Hyperspectral Imaging (HSI) is a non-invasive optical imaging modality that shows the potential to
aid pathologists in breast cancer diagnoses cases. In this study, breast cancer tissues from different
patients were imaged by a hyperspectral system to detect spectral differences between normal and
breast cancer tissues, as well as early and late stages of breast cancer. If the spectral differences in
these tissue types can be measured, automated systems can be developed to help the pathologist
identify suspect biopsy samples, which will improve sample throughput and assist in making critical
treatment decisions. Tissue samples from ten different patients were provided by the WVU Pathology
Department. The samples from each patient included both normal and ductal carcinoma tissue, both
stained and unstained. These cells were imaged using a snapshot HSI system, and the spectral
reflectances were evaluated to see if there was a measurable spectral difference between the various
cell types. Analysis of the spectral reflectance values indicated that wavelengths near 550nm show
the best differentiation between tissue types. This information was used to train image processing
algorithms using supervised and unsupervised data. K-Means and Support Vector Machine (SVM)
approaches were applied to the hyperspectral data cubes, and successfully detected spectral tissue
differences with sensitivity of 85.45%, and specificity of 94.64% with TNR of 95.8%, and FPR of
4.2%. These results were verified by ground truth marking of the tissue samples by a pathologist.
This interdisciplinary work will build a bridge between pathology and hyperspectral optical
diagnostic imaging in order to reduce time and workload on the pathologist, which can lead to benefit
of lead reducing time, and increasing the accuracy of diagnoses.
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Chapter 1
1.Introduction
Breast cancer is one of the highest cause of cancer deaths among American women [1], [2], [3],
[4]. According to the U.S. Breast Cancer Organization, statistics show that about 1 in 8 U.S.
women will develop invasive breast cancer over their lifetime [ 1 ] , [ 2 ] , [ 3 ] . In 2016, about
246,660 new cases of invasive breast cancer will be diagnosed in women, 61,000 new cases of
noninvasive carcinoma will be diagnosed in situ, and 40,450 women in the U.S. are expected to
die from breast cancer. These numbers are large enough to note that, other than lung cancer,
breast cancer death rates are higher for the U.S. women than any other cancer [1], [2], [3].

1.1 Motivation and Objectives
Hyperspectral Imaging (HSI) is a sophisticated non-invasive optical imaging modality that has the
potential to be applied toward medical imaging research and clinical practice. From imaging labs,
to National Institute of Health (NIH), to cancer institutes, hyperspectral imaging has been an
optical imaging tool that is used for providing spectral information, which can help in material
detection. Specifically, this research effort introduces a new tool that can help in breast cancer
detection by providing pathologists with a tool that can potentially make their diagnosis process
of ductal carcinoma under the microscope easier and more efficient [5]. This work is a
collaboration between the Lane Dept. of Computer Science and Electrical Engineering, the WVU
Pathology Department, and the WVU Medicine Mary Babb Randolph Cancer Center. The overall
scope of the work is to image samples of breast cancer tissues from different patients in order to
show the ability of the hyperspectral system to detect spectral differences between normal and
breast cancer tissues, as well as early and late stages of cancer, which will also effect the treatment
decision.
1

1.1.1 Problem Statement
The role of the pathologist is undeniably important for cancer diagnosis because their job as
physicians is to look at body fluids and tissues in order to help oncologists as well as other medical
specialists make a diagnosis [6]. However, as the number of breast cancer cases increases, the
pathologist’s job will become more difficult due to the increasing number of samples they need to
evaluate on a daily basis. Because the samples are provided via biopsy or surgical procedures, their
schedule will have to be compatible with the surgeons’ schedule. In addition, the pathologist will
also need to spend time preparing the samples, stain them, and finally, examine them under a
microscope for diagnoses.

1.1.2 Research Goals and Task Summary
The goal of this study is to evaluate the performance of a snapshot hyperspectral imager to see if
measurable differences in spectral properties can be observed between normal and various stages
of cancerous breast tissues fixed on biopsy slides, specifically in the case of ductal carcinoma. This
interdisciplinary work will build a bridge between pathology and hyperspectral optical diagnostic
imaging in order to reduce time and workload on the pathologist, with a secondary benefit of
leading to more accurate diagnoses. The hypothesis of this work that a hyperspectral imager can
be used to spectrally determine the difference between healthy and cancerous cells on both stained
and unstained slides, as well as spectrally determine the difference in cancer cells from varying
stages of cancer. A secondary hypothesis is that, if these differences can be seen and verified by a
pathologist, image processing techniques can be used to differentiate between cells in a semiautomated fashion. This technique will not replace the pathology work, however it will help
improve the pathologist’s workflow by pre-screening samples, allowing them to be prioritized for
examination based on the likelihood of cancer cells being present in the image. The hyperspectral
imaging system used for this work is a Rebellion Photonics snapshot HSI system. This camera has
the ability to collect images of the tissue samples across a broad range of wavelengths
simultaneously, creating what is known as a hyperspectral data cube. If spectral differences can be
clearly identified and measured, trained algorithms can potentially sort through the wavelengthspecific images contained in the data cube and identify cancerous and non-cancerous healthy tissue
in both stained and unstained tissue samples. This HSI system and associated image processing
tools can potentially be used to differentiate between the stages of the cancer cells being examined
2

based on spectral reflectance differences in breast cancer cells at different stages of progression,
which may add additional useful information for the oncologist.
Figure 1.1 is a general concept diagram shows how the pathologist can use the HSI technology in
order to make his or her job easier.

Pathology
Tech/Assistant
prepares samples for
diagnosis

All samples are
imaged by the HSI
system

Process the HS
images using the
trained algorithm for
spectral detection

Arrange and Sort
samples from the
highest probability
to lowest

Pathologist test
pictures of samples
for diagnoses

HSI Process

Figure 1.1: Concept diagram of how HSI can aid the pathologist in cancer detection and
diagnosis. Pictures (left to right): pathology tech [60], hyperspectral imager system at WVU,
image processing DCIS samples, pathologist diagnosing a sample on a monitor [59].
As Figure 1.1 explains the use of the hyperspectral imager system in the diagnosis process.
Pathologist uses the hyperspectral system to image the prepared samples, then a trained algorithm
is applied on the captured images, and sorts them in an order of priority (high-low) risk of breast
cancer. Finally a pathologist will make a diagnosis decision by looking at the prioritized images
of the biopsy samples.

1.1.3 Thesis Contributions and Impact
The tasks involved in this research are as follows:
Task 1: Hyperspectral System Setup – This task involves two experiments for the HSI system:
calibration and understanding how the hypercube is built with different spectral information.
Task 2: Cellular Imaging - Stained and unstained tissue samples from normal and cancerous
tissues from different patients were provided by the WVU Pathology Department. These cells were
imaged using the HSI system connected to a microscope in lab of Dr. Linda Davis, and the spectral
3

reflectances were evaluated to see if there was a measurable spectral difference between the
various cell types.
Task 3: Image Evaluation - After imaging, the large amount of data contained in the threedimensional hyperspectral data cube was evaluated using image processing techniques to look at
specific regions of interest in order to determine the spectral reflectances over the visible light
wavelength spectrum. The image processing and HSI toolboxes are used to analyze the data with
custom algorithms. These algorithms are a collection of machine learning algorithms for data
mining tasks that are contained in both MATLAB and Waikato Environment for Knowledge
Analysis (WEKA). The algorithms are used to learn the about the nature of the hyperspectral data
in order to understand the spectral reflectance value and how it reflects the tissue samples. An
overview of this work is given in the last section of this chapter.
This study has shown a great potential for opening new avenues of exploration in the field of breast
cancer optical imaging and diagnosis. Specifically, this research will add a new tool that may be
used not only in research, but also used by pathology in breast cancer diagnoses. The
interdisciplinary nature of the work has fostered a collaboration between the fields of Biomedical
and Electrical Engineering, Cancer Pathology, Cancer Cell Biology, Medical Imaging and Image
Processing, and has built a communication framework between those departments in West Virginia
University and other educational institutes.

1.2 Breast Cancer Overview
Cancer appears in the body when cells start to grow in an abnormal way. It can grow in any part
of the body, and spread to other areas of the body [1], [2]. Breast cancer, in fact, is considered a
tumor that starts from an individual cell, which then starts growing and dividing to form what is
known as malignant tumor. Learning about the anatomy of a normal breast (Figure 1.2) and how
cancer effects normal cells helps in better understanding how cancer interact within the body. The
female breast is made up of a variety of structures and tissues, including: lobules, which are glands
that can produce breast milk, and ducts, which are small tubes that transfer milk from the lobules
to the nipple, fatty and connective tissue, blood vessels, and lymph vessels [1], [2].
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Figure 1.2: Anatomy of female breast [2].

1.2.1 Types and Stages of Breast Cancer and
There are many different types of breast cancer, such as invasive and in situ ductal carcinoma,
invasive, pre-invasive lobular carcinoma, and the less common cases of different breast sarcomas
[1], [2], [4]. More than 80% of breast cancer cases are ductal carcinoma, which begins in the cells
that line the ducts [2]. Few breast cancer cases start in the cells lining the lobules. In addition, a
fewer number of breast cancers can also start in cells of the other tissues in the breast. These are
called sarcomas and lymphomas; however, these are not as common as the first two. Carcinomas,
the most common breast cancer, is also called adenocarcinoma, which is a type of cancer that starts
in the epithelial cells which line organs and tissues Sarcomas start in the cells of muscle, fat, or
connective tissue, are considered less-common types of breast cancers [2]. Sometimes, a
combination of different types of breast cancers may be found in one breast tumor. This research
work has been focused on two types of breast cancer, both in situ and invasive which are: ductal
carcinoma and lobular carcinoma [4]. Further explanation of these specific breast cancer types is
provided in the following sections
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Ductal carcinoma in situ (DCIS): DCIS is known as noninvasive (or sometimes, pre-invasive)
breast cancer [2]. In situ ductal carcinoma is first detected when the cells lining the walls of the
ducts have changed to appear abnormal. (Figure 1.3 [7]), and (Figure 1.5 [1]) exhibit atypical
biological, physical, and chemical behavior [7], or show drastic changes in cell-to-cell interaction
with neighboring cells [7]. In the case of DCIS, the cancer cells stay confined inside the milk ducts.
This characteristic is one clear difference between DCIS and invasive carcinoma; the cells have
not spread (invaded) through the walls of the ducts into the surrounding breast tissue [1], [2], [4].

Lobular carcinoma in situ (LCIS): From the name, LCIS are tumor cells that have grown to fill
the lobules. They grow over the cells that stay inside the milk-producing structures of the breast,
which are lobules themselves. The in situ lobular carcinoma is not considered invasive; however,
it is a considered a precursor for more invasive types of breast cancer [1], [2], [4].
Ductal carcinoma in situ (DCIS)

Figure 1.3: Anatomy of ductal carcinoma types [2]
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Figure 1.4: Pathology images of different types of breast cancer. (Left): High grade DCIS, (Middle):
Invasive Ductal Carcinoma. (Right): Invasive Lobular Carcinoma [7].

Invasive ductal carcinoma (IDC): Invasive ductal carcinoma is the most common breast cancer,
comprising approximately 8 out of 10 invasive breast cancers diagnoses. It first appears in a milk
duct of the breast, then breaks out the wall of the duct and progresses to infect the fat tissues of the
breast. It can also grow into the surrounding normal tissue inside the breast [1]. In addition, it may
also start to metastasize, which means to spread to other parts of the body through the lymphatic
system and bloodstream [2], [7].

Invasive lobular carcinoma (ILC): Invasive lobular carcinoma occurs in the lobules which are
the glands that produce milk. Being labeled as invasive, like IDC, it can also metastasize and
spread to other parts of the body. Statistics show that about 1 in 10 invasive breast cancers is an
ILC [2], [4], [7].

Figure 1.5: Abnormal duct tissue [1]
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1.2.2 Diagnosis and Detection of Breast Cancer
Early detection of breast cancer reduces the mortality rate and increases the survival chance. If a
patient is diagnosed with breast cancer, post-tests are performed for the purpose of confirming the
diagnosis, determining tumor stage & location, and to help determine the options for treatment
planning. There are several tests and procedures used for the purpose of diagnosing, detecting, and
confirming whether or not the patient has breast cancer. Diagnosing cancer is often not the work
of one individual. In most cases, the diagnosis is a team effort, involving of several specialists
from oncology, pathology, radiology, and surgery. It is critical that the following tests and
procedures are joined together to provide the patient the best and most appropriate diagnosis and
treatment plan that can be offered.
A) General Physical Examination and History: A general physical exam is often performed to
look at specific signs that could be considered abnormal, such as lumps or rashes. Also, the
patient’s long-term, short-term, and family health history are examined for previous history of
disease or symptoms.
B) Clinical Breast Examination: A breast exam is performed by the primary care physician or
other medical professional. In this procedure, the examiner carefully feels the breasts and the
region under the arms, searching for lumps or other abnormal or suspicious conditions.
C) Blood Chemistry Laboratory: A lab test procedure is performed on the patient’s blood sample
which is acquired via a common venipuncture procedure. Blood is examined for abnormal
numbers when compared to the patient’s usual, baseline blood chemistry, such as an abnormal
increase in the number of white blood cells, or reduced amounts of oxygen production.[3].
D) Clinical Trials: In addition to common office procedures and laboratory testing, the patient
can opt into clinical trials aimed evaluating new diagnostic breast cancer procedures, including:
evaluation and testing of nipple discharge, ductal lavage, and nipple aspiration exams [8].
E) Biopsy Test: A biopsy is a procedure whereby sample tissue is removed from a suspect region
identified by one of the previously described procedures. These tissue samples are then viewed
under a microscope by a pathologist to check for signs of cancer. Multiple elements could affect
the doctor’s decision of the best biopsy procedure. These elements, such as tumor size, location,
and presence or extent of spreading or growth, can vary in weight when considered for decision
making. The following are different types of biopsy procedures [3] [7]:
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Surgical biopsy: a surgical procedure that removes either part of a suspect lump, the whole
lump, or just a sample of tissue. (Figure 1.6-a).



Core Needle Biopsy: a wide needle (1/16 inch in diameter and 1/2 inch long) is used to
puncture and remove a tissue sample using the cutting tip of the needle (Figure 1.5-b).



Fine Needle Biopsy: a very thin, hollow needle attached to a syringe (smaller than core needle)
is used to remove a tissue or fluid sample from the targeted area (Figure 1.5-c).

A key component to most biopsies that is relevant to this research effort is that dye is often added
to the tissue sample. This dye enables a pathologist to easily view and evaluate the cells under a
microscope. In many cases of breast cancer, pathologists use Hematoxylin and Eosin (H&E) dye
(Figure 1.6 d-e).

a

c

b

e

d

Figure 1.6: (a-c) left to right: surgical, core, and fine biopsy needle.(d-e) H&E dye, stained tissue [9]

F) Medical imaging: For many decades, medical imaging has been one of the main, if not the
main, diagnostic tools of many diseases. Development of a wide range of medical imaging
modalities has enabled many application areas for these technologies, ranging from research to
diagnostic imaging and treatment. Particularly, in breast cancer cases, several imaging modalities
are used for detection, diagnosis, and the development of treatment plan to improve the quality of
life of the breast cancer patient. These imaging methodologies are described in detail in the next
section.
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1.3 Breast Cancer and Medical Imaging
Different imaging modalities are used for breast cancer, ranging from ionizing and non-ionizing
radiation to optical imaging. A short description to some of those modalities is provided as follow:
A) Mammogram: A mammogram is an x-ray of the breast. For this procedure, the breast is
pressed between 2 plates to flatten and spread the tissue in order to image a large surface area of
the breast tissue simultaneously. If the image shows any abnormal structures, the patient is urged
to have other tests to acquire additional information that can be applied to form a diagnosis [10]
[4].
B) Ultrasound: An ultrasound scan uses sound wave echoes to outline the imaged part of the
breast tissue in order to create a picture. Ultrasound images are usually viewed in real-time to help
locate the target for a physical biopsy [10], [11].
C) Breast MRI: High magnetic field and radio waves are used to look at very deep details of
structures within the breast, which can help in diagnosis. This technique is not the primary imaging
tool for all breast cancer patients, it is used for extracting deeper breast structural information about
a specific patient [10], [12].
D) PET/CT of the Breast: This imaging method is an advanced imaging technology that
combines Positron Emission Tomography (PET) with Computed Tomography (CT) to detect small
tumors. This technique is also used to evaluate patients after breast cancer has already been
diagnosed to monitor tumor activity, such as growth or spreading [13], [10]. This technology uses
radiopharmaceutical drugs that are attracted to the cancer cells, after the patient is injected with
the drugs, they can appear on the PET/CT that detects the emission photons and converts them to
light signals that resulted by the radioactive decay [13].
E) Optical Imaging: Many optical imaging modalities have been involved in a variety of cancer
applications including: optical coherence tomography, confocal microscopy, multiphoton
microscopy, multispectral and hyperspectral endoscopy, and microscopy [14], [15], [16], [17].
Other optical imaging methods which take advantage of the optical properties of materials and
apply optical imaging methodologies to diffuse reflectance imaging have recently emerged with
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significant potential for non-invasive, portable, and cost-effective imaging for biomedical
applications spanning tissue, cellular, and molecular levels [15], [16].

1.4 Hyperspectral Imaging (HSI)
1.4.1 Hyperspectral Imaging: History and Overview of Operation
Hyperspectral Imaging (HSI) is a well-studied optical imaging technology that was first developed
for applications such as space exploration and Earth observation, satellite surveillance, agriculture,
and industrial applications [17], [18], [19], [20]. NASA and U.S. Army scientists were the first in
discovering and taking advantage of the spectral sensing technology. HSI technology, when
properly exploited can provide the Army with additional and improved automated terrain
analysis, image understanding, object detection, and material characterization capabilities, as
shown in Figure 1.7 [17]

Figure 1.7: HSI remote sensing system in geographical and agricultural application [17].
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HSI creates a 3-dimensional data structure known as a data cube which contains the spatial image
detail (x & y coordinates) as well as detailed spectral information along the z-axis. The spectral
information of each co-registered pixel allows investigator to trace, detect, and extract additional
information from a target, such as a spectral signature.

1.4.2 How Hyperspectral Imaging Works
In order to understand the operation of an HSI system, is it helpful to compare the output of a
HSI system to a typical Red, Green, and Blue (RGB) camera or imager. RGB represent the color
sensitivity of the imaging pixels, where red, green, and blue are combined in various proportions
to obtain any color in the visible spectrum [21], which will also be explained later in Chapter 2
in the section that talks about the visible light spectrum ranging in wavelength between about
390 to 700 nm. Digital cameras have image sensors, such as CCD (charge-coupled device) and
CMOS (complementary metal-oxide semiconductor) imaging arrays, which convert light into
electrons to produce an image [21], [22]. As explained, the RGB images are a combination of
different pixel intensities from discreet RGB pixels that combine to give our human eyes
the appearance of covering the entire visible spectrum. As it is a discretized red green and
blue image resulting from the input of a continuum of wavelengths, the image data is
combined and smoothed in order to get one colorful image, and that will result of losing
valuable data, which can only appear in by not combining the wavelength bands [23] [24].
However, in the HSI case, one image is broken down into tens or even hundreds of images
with different wavelength channels, or bands. The images of the different bands will have details
in each wavelength that might have been not seen by conventional RGB imagers. This is the
main advantage of hyperspectral imaging, as shown in Figure 1.9. Hyperspectral imaging should
not be confused with multispectral imaging. A simple way to differentiate between both terms
is by the number of bands. Multispectral imaging often uses ~10 discreet spectral bands with
center wavelengths separated by several nanometers of wavelength. Hyperspectral imaging uses
a large number of spectral bands often separated by only 1-2 nm, allowing the construction of
a hyperspectral data cube with rich, continuous spectral information. This defining
characteristic gives the hyperspectral imagers the advantage of capturing very detailed spectral
information for each pixel in an image, as seen in Figure 1.8.
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Figure 1.8: RGB image wavelength intensity spectrums [23]

Figure 1.9 Multispectral and Hyperspectral imaging number of bands [23]

As HSI creates a three dimensional hypercube, depending on the capability of the HSI system,
each pixel in the hypercube can be characterized by a spectral curve, which can range from the
UV to IR regions as shown in Figure 1.10 [24] [25].
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a

Figure 1.10: a) hyperspectral cube. b) pixel spectrum in the spectral dimension

1.4.2.1 The development of hyperspectral imaging technology over time
Before Snapshot Hyperspectral technology was invented, the spectral hypercube was built and
created by what is called a line-scan hyperspectral imager [25]. There are two different types of
line-scan technology, described as follows:
Spatial Scanning, where two-dimensional scanning sensor output represents a full slit spectrum
(x,λ), and scan along the y-axis. The optical slit is basically used to provide a fixed or adjustable
aperture and controls the angle of the light which enters through. Hyperspectral imaging (HSI)
devices for spatial scanning obtain slit spectra by projecting a strip of the scene onto a slit and
dispersing the slit image with a prism as shown in Figure 1.11-A [26].
Spectral Scanning, is also a form of two-dimensional scanning sensor. However, the slit spectrum
is in (x,y), the scan is performed along, and scan through different wavelengths (λ), which is the
spectral dimension, more information about how to scan through different wavelengths will be
provided in Chapter 2 . However, each 2-D sensor output represents a single-color monochromatic
image, as shown in Figure 1.11-B [26].
In both types of line-scanning system, optical filters, called line filters, are integrated with the
camera sensor, [26], [27]. In the case of the spatial scanning, line scan hyperspectral cameras scan
the image line per line [27]. The advantage of line scanning is being able to pick and choose
spectral bands, and having a direct representation of the two spatial dimensions of the scene in the
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spectral scanning case [26], [27]. Line scanning systems have also been used in remote sensing,
where it is sensible to use mobile platforms. It has also been used to scan materials in mining and
agriculture applications [27]. The disadvantage however, line scanning system require time to scan
through all of the wavelengths, which requires a stable camera mount and nonmoving image target.
Time of scanning vary depends on the size of the image, the integration time, and the acquisition
speed of the camera. System vibrations and target movement have an impact on the accuracy and
reconstruction of the image [27].

Figure 1.11: Scanning and non-scanning to build the hypercube [53]

Snapshot (non-scanning) hyperspectral camera
The snapshot hyperspectral camera is able to capture an entire hyperspectral image, in which all
of the wavelengths are captured instantly, then the hypercube is created. Snapshot hyperspectral
technology is designed and built in different configurations than the line scan camera [27] [29]. It
uses a prism to break up the light, and the diffracted wavelengths fall on different portions of the
imaging sensor. Software is used to sort the varying wavelengths of light falling onto different
pixels into wavelength-specific groups. While conventional line-scan hyperspectral cameras build
the data cube by scanning through various filtered wavelengths, or an object, the snapshot HSI
acquires an image, and the spectral signature at each pixel, simultaneously. Snapshot systems have
an advantage of faster measurement, and also sensitivity improvement, so that measurements that
were previously starved for light are now possible [53]. However, one drawback is that the
resolution is limited by down-sampling the light falling onto the imaging array into a smaller
number of spectral channels Figure 1.11-C shows the snapshot hypercube.
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For the past two decades, different research has shown the potential and effectiveness of using
HSI technology in medical applications, which HSI has been used as a noninvasive, and
nonionizing imaging diagnostic tool [5], [15], [17], [23]. HSI has been used in many medical
applications in the exploration of anatomy, physiology, and pathology. Also, beyond the visible
spectrum, HSI can be used for optical biopsies which involve in vivo diagnosis of tissue
without the need for sample excision and processing [5], [16], [30]. These applications take
advantage of the spectral information contained in light that passes through (transmission) or
reflects off of (reflection) different materials, which are fundamental properties associated with
transmission and reflection spectroscopy [14], [15], [16] Specific to reflection spectroscopy,
spectral reflectance is defined as the ratio of reflected energy to incident energy as a function of
wavelength [19], [20]. These spectral reflectance curves are used for the identification of different
materials, which is why HSI has an advantage over the other imaging systems that can’t reach
such information [20]. More information will be provided in Chapter 2 (Theory) on how
hyperspectral imaging works, and how spectral reflectance curves are collected to provide a
valuable spectral information that can be used for many applications.

1.4.3
1.4.3.1

Hyperspectral Imaging Applications
General applications

HSI remote sensing systems sense the light that is reflected from objects that are usually some
distance away from the sensing system. Many applications of HSI technology involve airborne
and satellite-borne systems. The light that is sensed by a remote sensing system is affected by the
distance between the system and by the source of the light. Any HSI system must account for these
effects when comparing sensed spectra to spectral signatures. This technology has been used in
many applications in geology, agriculture, and military target detection. As each material reflects
different spectral signature, the HSI systems can identify the materials remotely. In geology,
hyperspectral imagery has been used to study the geography of the different parts of the Earth’s
surface, which helps in the observation and study of changes that may take place over time due to
natural or man-made causes. [32] [33]. In agriculture, the HSI system is also used to study
characteristics such as soil quality, to determine the best regions for agricultural projects [34]. The
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HSI systems are also used for military target detection to locate and identify camouflaged tanks or
bases as shown in Figure 1.12. [35]

Figure 1.12: HSI remote sensing [35]

HSI systems are also used in the food industry. Automated HSI applications used for quality
control on production lines is a promising application [36], specifically due to an improvement of
acquisition time and data processing speeds enabled by modern CMOS and cameras and computer
processors. HSI system can also be used to detect fungal diseases and bacterial contamination in
fruits and vegetables by looking for variations in spectra caused by biochemical and
physicochemical processes associated with the undesirable organisms [37]. HSI has also been
applied to the detection of food freshness by the measuring the percentage of fat and sugar to
determine how moisturized the product is [38].

1.4.3.2

Hyperspectral Imaging Medical applications

In the last two decades, HSI has been used in several medical applications including: disease
diagnoses and screening, real-time surgical monitoring, diabetes-related wound monitoring, and
white/red blood cell differentiation [39], [40], [41]. The details of a selection of these applications
most closely related to this research effort are provided in the following sections.
1.4.3.2.1 General Medical Applications: Researchers at the University of Texas Southwestern
Animal Lab have been using the HSI technology in renal surgery. They use the HSI to monitor
blood oxygenation levels in real- time before after and during surgery. This will help in preventing

17

the risk of or predicting the likelihood of renal failure after surgery. They also use HSI during the
implementation of pharmacologic solutions to monitor kidney function to predict what might
happen to patient during, and after surgery [44]. HSI has also been used in the cases of diabetic
wounds to investigate hemoglobin saturation to help predict the ulcerations and track the healing
of the diabetic foot ulcers as shown Figure 1.13 [42]. Ongoing research at WVU is aimed at using
an HSI system to image and segment human white blood cells flowing in vessels to enable white
blood cell counting without drawing blood as shown in Figure 1.13 [43].

Figure 1.13: (left-top) RGB, and HSI images of healing diabetic foot showing a regular oxygen flow around
the ulcer, which cannot be seen in the unhealed case in the (left-bottom) [42]. On the right side, HSI of the
flat field calibration, and the image segmentation of the white blood cells count project [43].

1.4.3.2.1 HSI and Cancer
In general, optical imaging has also been widely used in oncology applications in both clinical and
research settings. In fact, hyperspectral imaging has been used in detecting skin cancer in
dermatology clinics [45]. In addition, many cancer research centers are exploring a variety of HSIbased research [46], which will enable a large expansion of clinical applications of HSI technology
in the near future. Examples of different applications of HSI in the cancer field are provided below.
HSI has been a very useful tool in skin cancer investigation [48]. Several melanoma and skin
sarcoma cases have been confirmed using HSI system. The HSI noninvasive screening system will
may increase the speed of diagnoses and melanoma detection as shown Figure 1.14 [47].
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Figure 1.14: spectrum of different pixels in the skin tissue showing the ability of the hyperspectral system
of detection skin cancer [47].

Research conducted by a team at Emory University has demonstrated HIS-based prostate cancer
detection in mice. The idea is to use the spectral difference of tissues contained in the HSI data in
order to enhance the detection of cancer tissue. Two different methods have been explored in this
study. The first was to detect spectral differences, then create a method to highlight the differences
of the reflectance properties of cancer versus those of normal tissue in tumor-bearing mice and on
pathology slides. This imaging method may be able to help physicians to dissect malignant regions
with a safe margin and to evaluate the tumor bed after resection [48]. This study may lead to
advances in the optical diagnosis of prostate cancer using HSI technology [48].

Figure 1.15: a spectrum taken from a tissue showing the spectral reflectance value of normal and prostate
cancer tissue [48]
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1.4.4 Data Analysis and Image Processing of Hyperspectral Imaging
Data Analysis and Image Processing are two main components of a complete imaging system that
is used for analyze, and process images as well as material detection. These fields use standardized
algorithms and functions to analyze, explore, and examine an image [49]. The images can also be
visualized in specific conditions with focusing on regions of interest (ROIs). Image processing
also allows for performing image analysis, image segmentation, image enhancement, noise
reduction, geometric transformations, and image registration [50]. It can also be applied on specific
data information per pixel, so image processing can be used to explore examine a region of pixels
[49]. Image analysis is the process of extracting meaningful information from images such as
finding shapes, counting objects, identifying colors, or measuring object properties [50].
1.4.4.1 HSI Image processing: In the application of HSI systems, image analysis enables the
extraction of diagnostically-useful information that is taken from the hyperspectral data cube set
at the tissue, cellular, and molecular levels [51], [52]. The data that is extracted from the
hyperspectral images is not only considered a three-dimensional data set, it also provides specific
spectral information per pixel, so image processing also enables examination of a specific spatial
region of pixels [51]. Therefore, advanced image analysis, and classification methods for
hyperspectral datasets are required to extract (unmix) spectral data and classify relevant spectral
information [52]. Image analysis can also be defined as the process of extracting meaningful
information from images such as shape detection, object counting, identifying colors, or measuring
object properties [49] [50] [51]. In addition, the goal of applying hyperspectral imaging in this
work is not only to identify clear spectral deference between healthy and malignant in breast tissues
and provide pathology with an additional tool for strategic diagnosis, but also in advanced stages
to break down the spectral mixtures into a spectral signature of molecular fingerprints with disease
states and stages [45], [50], [52].
A general summary of the basic steps used for hyperspectral image analysis involve preprocessing,
feature extraction and feature selection, and classification or unmixing, which applies different
analysis methods to the data cube in order to get a better understanding of the image and spectral
content and to extract some useful information that cannot be seen or observed using conventional
RGB camera technology [53], [54]. Chapter 2 talks in more details about image processing, image
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clustering, and segmentation, explaining why and how applying different algorithms will benefit
the user. A short description of the two related image processing algorithms used in this research
effort are provided in the following sections.
1.4.4.2 Image Processing Algorithms for Hyperspectral Imaging.
K-means clustering, and Support Vector Machine (SVM), are two different data analysis
algorithms that is used in this work to provide different ways of analyzing HSI data to help confirm
diagnosis and detection.
1.4.4.2.1 K-means is a learning algorithm that can be applied to solve unsupervised data
classification problems. It starts first by choosing a number of classes (clusters). The main idea is
to define ‘k’ centers, one for each cluster [56]. These centers should be placed in a certain way
because of different location causes different result. So, the better choice is to place them as much
as possible far away from each other [57]. The next step is to take each point belonging to a given
data set and associate it to the nearest center. In this case, each class will have one centroid, and
the many times the experiment is running the better stable result will be, also the more data the
classifier is given, the closer better accurate centroid will be picked [56].
1.4.4.2.2 In the case of SVM, it is a classifier that can identifies and creates a hyperplane that
separates between the different classes [58]. In other words, given labeled training data, the
algorithm outputs an optimal hyperplane which categorizes new examples figure 2.3 in Chapter 2.
This will happen only if the data is linearly separable. The optimal hyperplane is the best
hyperplane that have the maximum separation distance [59], [60]. Different SVM algorithms were
developed based on how to separate between classes in the data, and that is always depends on the
data itself [58].
In summary, the aim of this study is to add a new tool and platform in breast cancer ductal
carcinoma diagnosis, by evaluating the performance of the optical imaging snapshot hyperspectral
imager to measure and explore the differences in spectral properties, which may be observed
between normal and various stages of DCIS breast tissues fixed on biopsy slides. As a result, this
interdisciplinary work will build a bridge between pathology and hyperspectral optical diagnostic
imaging in order to reduce time and workload on the pathologist, which can lead to benefit of lead
reducing time, and increasing the accuracy of diagnoses.
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1.5 Thesis Overview
This work effort is aiming for applying Hyperspectral imaging technology to help pathology in
breast cancer ductal carcinoma diagnosis. Specifically, the HSI system will be trained to image
pathology biopsy samples from patients and then, in semi-automation method, the samples will be
sorted by the priority of which samples appears more likely cancer from the others. This step will
reduce time and workload on the pathologist, which will also lead to more accurate diagnoses. The
thesis is organized as follows: Chapter 2 describes a theory of light reflectance in different
materials, then the fundamentals of how hyperspectral imaging works in details, and finally a
summary of the mathematical approaches of the image processing algorithms used in this study.
Chapter 3 provides the setup and testing steps of the HSI system, which is the first step to
understand the hyperspectral imaging system that is used in the work. Also, applying different
experiments to test the system with different experiments in order to have a clear image of the
spectrum depends on the light source. Two main experiments are done after the system calibration
which are called: HSI leaves experiment, and three pathology slides preparation method. Chapter
3 also provides the cellular imaging samples, where samples of stained and unstained tissues are
imaged where studying the spectral difference between the normal and cancer tissues as well as In
situ and invasive mammary cancer in mice. The samples were manually marked by pathologist, to
show the differences in the spectral reflectance that the HSI system can show between the normal
and the cancer tissues, as well as the in situ with the invasive cases. Chapter 4 approaches the
results of applying the image processing algorithms to train the system for the hyperspectral date
detection. Two different algorithms are used, the first one is K-means algorithm that will be applied
on unsupervised data and creates two different classes for detection. The second algorithm is
support victor machine (SVM) that will be applied on a supervised data to test the detection ability
Finally, the last chapter (Chapter 5), a conclusion of the work with discussion and summary, then
the future work that might be in continuation of this work
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Chapter 2
2. Theory
2.1 Introduction
This chapter provides a detailed description of the theory of light reflectance in different materials,
how different shapes, structures, and components of materials can react to different light sources,
and how it relates to hyperspectral imaging. The next sections will provide fundamentals of the
hyperspectral imager, and how the reflected light travels through the optical components to build
the hyperspectral image, the hyperspectral data cube. This Chapter also, provides the fundamentals
of spectrometer, spectral reflectance, spectral signature, and how the overall hyperspectral imaging
system works. Finally, the last section will include a summary of the mathematical approaches of
the different image processing algorithms used in this study.

2.2 Basic principles of light
Light is a form of electromagnetic energy. As light travels through a medium, it interacts with the
medium in different ways depending on the medium material and other properties. Three of the
main interactions are: absorption, transmission and reflection as shown in Figure 2.1 [61], [62].
Light absorption occurs when the energy is transferred from electromagnetic waves to molecules
of the medium. [61]. Transmission, however, occurs when electromagnetic waves of the light
move through a material. Reflection occurs when electromagnetic waves of light reflect off a
medium [62].
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Figure 2.1: light interaction with medium [61]

Light waves range in wavelength from 400-700 nm as shown in Figure 2.2 [61]. Absorption,
reflection, and transmission are all wavelength-dependent phenomena, a critical component to the
operation of hyperspectral imagery.

Figure 2.2: light spectrum [61]
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2.3 The theory of reflectance
Hyperspectral imaging spectroscopy has the capability to identify or detect specific materials
based on their spectral reflectance. In order to get accurate and useful results, the hyperspectral
imager system handles raw image data in several steps, ending by processing the captured data
with a software by applying algorithms for material spectral reflectance for identification and
detection [14]. However, spectral reflectance varies upon the nature of materials and the reflected
surface that interacts with light. Reflectance of light can be clearly understood by understanding
the Bidirectional Reflectance Distribution Function (BRDF), which quantifies the geometric
radiance distribution which results from the reflected light [15]. To clearly understand BRDF, it is
important to explain some of the fundamentals of electromagnetic waves, which leads to defining
the Fresnel equations, and then the BRDF.

2.3.1 Electromagnetic waves
The electromagnetic plane wave that has the orthogonal x and y components of the electric field
vector, which travels in the z direction may be expressed by the following equation:

𝜀⃗(𝑧, 𝑡) = ( 𝜀0𝑥𝑖 + 𝜀0𝑦𝑗)𝑒 𝑖(𝜔𝑡−𝑘⃗⃗.𝑧⃗)

Equation 2.1[62]

where 𝜀⃗ is the magnitude and direction of the electric field [V/m] in the x-y plane as a function
of position, z, and time, t. ε0x, and ε0y, are complex electric field projected onto the x- and y-axes.

𝑘⃗⃗ is the propagation direction vector, or wave vector, given by:
2𝜋
𝑘⃗⃗ =
𝜆
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Equation 2.2

where λ is the wavelength The angular frequency ω can be found using :

𝜔=

2𝜋𝐶
𝜆

Equation 2.3

where c is the speed of propagation of light in a vacuum.

2.3.2 Fresnel equation and optical scattering
As light hits an object or surface, reflection, absorption, and transition are summed to unity. Fresnel
equations provide the reflection and transmission magnitudes of an electromagnetic wave incident
on a material [15]. The reflection and transmission are a function of the angle and polarization of
the incident electromagnetic wave [16]. For the purposes of applying the equations, the orthogonal
polarization components are defined relative to the plane of incidence. The component of the
electric field perpendicular to the plane of incidence is called S-polarization. Reflection and
transmission are given by:

𝑟𝑠 =

𝑡𝑠 =

𝜀𝑟
𝜀𝑖

𝜀𝑡
𝜀𝑖

𝑠=

𝑠=

−sin(𝜃𝑖−𝜃𝑡)
sin(𝜃𝑖−𝜃𝑡)

2sin𝜃𝑡 𝑐𝑜𝑠𝜃𝑖)
sin(𝜃𝑖−𝜃𝑡)

Equation 2.4[15]

Equation 2.5[15]

where θt is the transmission angle given by Snell’s law as:

−1

^
𝑛
𝑖

𝜃𝑡 = 𝑠𝑖𝑛 ( ^ sin 𝜃𝑖)
𝑛𝑡

Equation 2.6

where 𝑛𝑖 and 𝑛𝑡 are the complex indices of refraction of the incident and transmitted mediums
^

^

.
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2.3.3 BRDF equation
The optical property of a surface light reflection is usually described by the bidirectional
reflectance distribution function (BRDF). It shows how light is reflected into different directions
[17]. It is also defined as the ratio of the radiance scattered into the direction described by the
orientation angles (θr, ɸr) to incident irradiance from (θi, ɸi), as seen in Figure 2.3.

𝑓=

𝐿(𝜃𝑡 ,ɸ𝑖)
𝐸(𝜃𝑡 ,ɸ𝑖)

[𝑠𝑟−1 ]

Equation 2.7[62]

Figure 2.3: The geometry of light reflection [17]

2.4 Hyperspectral imaging system overview
Hyperspectral imaging is an optical imaging modality that collects and analyzes spectral
information from a wide range across the electromagnetic spectrum. Hyperspectral imaging also
has advantages over regular imaging in that it is provides spectral reflection or absorption
characteristics of the object being imaged in the form of spectral channels contained in an image
data hypercube [17]. The hypercube is essentially a three-dimensional dataset, which means even
a single pixel contains a feature vector with over 10 dimensions with an entire spectrum of
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reflectance information [18]. The technology of the hyperspectral imager requires using optical
sensors, which are adjusted to collect spectral information in several narrow bands or channels,
and typically these channels are in range between 2-10nm wide. Hyperspectral imaging sensors
produces image data in dozens or hundreds of narrow spectral bands [18], [19], [63], [64]. HSI
technology, when properly exploited can be used in optical imaging applications such as satellite
remote sensing, providing an additional and improved automated terrain analysis, image
understanding, object detection, and material characterization capabilities, as shown in Figure 1.6
[17]. Hyperspectral imaging can also be used in optical medical imaging in clinical and research
applications such as the work described here focused on breast cancer tissue detection (Figure
2.4). The information that is collected from the imaging system can be analyzed to obtain a
continuous spectrum for each image pixel or cell. Areas targeted by the imaging system may have
different biological, and chemical compositions that can detected by the sensor due to differences
in light reflection or absorption. The image spectra can be compared with field or laboratory
reflectance spectra in order to recognize and map surface materials such as particular types of
vegetation or diagnostic minerals associated with ore deposits [63]. Hyperspectral images have
valuable data, which requires an understanding of exactly what properties of ground materials we
are trying to measure, and how they relate to the measurements actually made by the hyperspectral
sensor [63].

Figure 2.4: Regular image of the breast tissue, hyperspectral image, and the spectrum of the
marked pixel.
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2.4.1 Hyperspectral System Hardware
The optical and spectral characteristics of a hyperspectral imaging system are determined largely
by the application requirements [26] [27]; however, all systems have the same basic components
that are assembled to achieve a common goal: to image the object, and provide both a spectral and
spatial dataset. The hyperspectral imaging system, basically built together as one optical system,
consists of a suitable objective lens matched to the spatial and spectral requirements of the
application [63]. Figure (2.5) shows how the reflected light of the imaged target travels onto the
entrance slit in the spectrograph. This light is dispersed into different wavelengths by the prism in
a spectrograph, such as an ImSpector (spectrograph) [64]. The optical slit, imaging spectrograph
and proper detectors to collect the spectral, and spatial information are all required optical elements
to build a proper hyperspectral imager. Figure (2.5) also describes how the ImSpector system
works.

Figure 2.5: Hyperspectral camera hardware

First the reflected light travels through the objective lens then to the slit of the main element of the
spectrograph. The image that is captured by the camera sensor as a two dimensional image, the
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spatial position and, λ as the spectral dimension. In order to capture the entire image, snapshots of
every line across the target area must be captured [64]. The slit, grating and detector characteristics
determine the spectral resolution as well as spatial resolution is determined by the pixel size. The
imaging spectrograph elements, and the Prism Grating Prism (PGP) imaging component are
explained in more details in the following section.
A) ImSpector (Imaging Spectrograph): The ImSpector - developed by SPECIM manufacturer is an imaging spectrograph that has the capability to be attached and combined with a many
monochrome imaging systems to form a spectral camera [66], [67]. Figure (2.6) shows the basic
example of an ImSpector. Each ImSpector consists of an input slit, collimating optics, transmission
grating and focusing optics as Prism Grating Prism (PGP) in a rugged package [67]. The ImSpector
produces a flexible wavelength selection that can simultaneously cover a broad spectral range, and
results of a high quality spectral and spatial resolution image [69].
B) Hyperspectral Prism Grating Prism (PGP) imaging component: Prism Grating Prism is the
main component that is located in the heart of the Imaging spectrograph. The PGP is designed as
two identical prisms: short and long pass filters are placed in between grating and the prisms. The
main objective controls the spectral response, and both filters within the PGP contain the aperture
stop. PGP also allows the spectrum to be centered, in which when optimized, refracts the spectrum
so that the light spots of both ends are similar.

Entrance Slit

Lenses,
PGP component

Figure 2.6 ImSpector Imaging Spectrograph

C) Hyperspectral imaging optical filters: Optical filters have been used in the hyperspectral
imaging systems for the wavelength selection method. Specifically, Tunable Filters (TF) are
normally used in the hyperspectral imager as shown in Figure 2.7. A TF is a device in which
spectral transmission can be electronically controlled by applying voltage (in the case of liquid
crystal Tunable Filter -LCTF-), or acoustic signal (in case of Acousto Optical Tunable Filter 30

AOTF-). These two filters are the most common electronical filters that have been used in
hyperspectral systems [66].

Figure 2.7. TF in hyperspectral systems

The main difference between LCTF and the AOTF is that LCTF is made with a stack of polarizers
and tunable liquid crystal plates that work as band pass filter; whereas the AOTF consists of a
crystal in which radio frequencies (RF) acoustic waves are used to separate a single wavelength of
light from a broadband source. The wavelength of light selected is a function of the frequency of
the RF applied to the crystal [15], [16].

2.4.2 Spectrometer of imaging system
The two main structural component of the Hyperspectral imager system are the spectroscopy and
the imaging systems. As pointed out, the imaging system can be attached to any optical device
from satellites to microscopes to endoscopic medical systems. Spectroscopy is the study of light
that is emitted by or reflected from materials and its variation in energy with wavelength [18].
Typically, applying light to the imaged target, which can be any type of light source in the
laboratory or sunlight in the field, in order to diffuse the reflectance and the scattering of targeted
materials at the surface [18] [19] [20]. In the hyperspectral imaging system, the spectrometer
measures the reflected light intensity from different materials. The semi-automated algorithm in
the imager system will then compare the collected information to a built-in spectral library for the
detection purpose. The detection starts when an optical dispersing element such as a (grating) or
prism (that can be seen in Figure 2.4) in the spectrometer splits this light into many wavelength
bands and the energy in each band is measured by a separate detector [65]. The spectrometer then
will be able to build a set of spectral measurements with using many detectors together, and get
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measurements of spectral bands as narrow as 2 nanometers over a wide wavelength range [66]
[67].

Depending on the application, and the optical component capability, the wavelength range includes
visible to infrared. The hyperspectral imager that is used for this work covers the visible spectrum
that’s corresponds to a wavelength range of 400 – 700nm. Hence, the work provided in this study
cases is designed to focus on the measurements of the light reflected from many adjacent areas on
the tissue sample surface on the pathology slides. The recent hyperspectral imaging (HSI) systems,
uses a snapshot imager, which allows creating the whole hyperspectral image cube within one
snapshot. However, in order to understand how the image is built, Figure 2.8 shows how one
hyperspectral reflectance build each pixel in the hypercube.

Dispersing element
Scan Mirror

λ

Imaging Optics

Detectors

Sample image (Breast Cancer Tissue)

Figure 2.8: Schematic diagram of the basic elements of an imaging spectrometer

2.4.3 Hyperspectral imaging and spectrometer
This section provides the different terms and keywords that are very important in the understanding
of a hyperspectral system, from spectral reflectance to spectral signature to spectral library:
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A) Spectral Reflectance: Spectral reflectance is the key to understanding how hyperspectral
images are created and built. It is basically the physical and fundamental characteristics in
spectroscopy of reflected light considering the reflected energy as a function of wavelength to
measure the spectral information [66]. Reflectance differs within a wide range of wavelengths in
almost every different material because energy at certain wavelengths is scattered or absorbed to
different degrees [67]. These reflectance variations are evident when comparing spectral
reflectance curves for different materials (Figure 2.3) [17]. The overall shape of a spectral curve
and the position and strength of absorption bands, in many cases, can be used to identify and
discriminate different materials [65].

B) Spectral Signature: As reflectance is a physical property of the object surface. It is defined as
the percentage of incident electromagnetic radiation of each wavelength that is reflected by the
object [20]. In addition, each object will have different spectral information depending on the
physical and chemical properties.That spectral information is called the spectral signature, which
means that every material will have a spectral signature value, or range of values [20].

C) Materials and Spectral Imaging: Spectral reflectance that indicates the spectral signature can
be observed in two different ways: 1) the wide range of the wavelength spectral dimension which
includes visible light, near infrared, infrared and the rest of the spectrum and 2) the structural and
chemical makeup of the material itself. That is the reason dealing with hyperspectral data from
capturing the land surface, is different than the data in which was generated by captured human
tissue. However, the basic principles of using the hyperspectral imaging will stay the same [64].
One of the main parameters that can show differences in the spectral information in different
materials is chemical composition and crystalline structure, which has a very strong impact on the
trend of the spectral curve [68]. In addition, wavelength, which is considered the spectral
dimension, will reflect at different values of absorption of each particular material. This variation
may be caused by the presence of particular chemical elements or ions, the ionic charge of certain
elements, and the geometry of chemical bonds between elements, which is governed in part by the
crystal structure of the material [68]. In this study, however, the work is applied on human and
mice breast tissue, where the differences within the tissue is very slim because the combination of
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cells and parameters within tissues have a lot in common that make a very close spectral curve. In
contrast, cell behavior and some chemical elements such as protein, effects cell and tissue activity
that cause a difference in the light absorbance, which result in different spectral reflectance values
[69].
D) Spectral Library and Spectral Detection: A spectral signature is the spectral information that
can be used to differentiate one material or groups of materials from another [70]. In general cases,
the spectral signature of a certain material or element is the same, and the absorbance and
reflectance that reflects the physical and chemical properties will not change. In addition, the
spectral information of each material within a certain range is saved in what is called a spectral
library. The spectral library is a digital library created by researchers at the Spectroscopy Lab by
measuring the spectral reflectance of hundreds of materials in a laboratory setting, creating a useful
reference resource for material identification in a variety of applications [70].

2.4.4 Hyperspectral data cube
When comparing between hyperspectral line lcan, and hyperspectral snapshot imaging methods,
it is important to look at both imaging techniques, as well as advantages and disadvantages of both
systems. In the case of line scan, each image collects one wavelength after the other, and the field
of view of the imaging system is fixed in order to build the hypercube as shown in Figure 2.9 [26],
[27]. However, in the case of the snapshot method, both spatial and spectral information of the
target are captured with one exposure [29]. The snapshot method is an imaging technique that does
not require scanning at all. As shown in Figure 2.9, the snapshot camera, has the capability to
produce a complete spectral data cube in a single integration by directly imaging the target zones
onto the spectral, and spatial detectors simultaneously [28], [29]. In the line scan method, time and
stability are required, and it is necessary to wait until all wavelength images have been recorded,
which that takes between seconds to minutes of measurement time plus few seconds between scans
depending on the imaged target and the imager capability from illumination and integration
conditions [25].
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Figure 2.9: building the spectral data cube in both line scan, and snapshot systems.
Thus, the accuracy of the hyperspectral data cube may decrease if an object is moving. The
snapshot method on the other hand, does not need the time that the line scan uses acquire to build
the hyperspectral data cube, which is an advantage over using the line scan system, however, its
spatial and spectral resolutions are limited as the total number of voxels cannot exceed the total
number of pixels on the camera sensors [28]. In addition, both methods should produce spatial and
spectral image quality across the output field of the spectrograph that is essentially the same at all
points on the detector, to result in an image with high spectral resolution [27]. However, if the
overall resolution is given by a certain number per channel, the line scan will produce an image
per line to have the full resolution per spectral channel, while the resolution is divided by number
of spectral channels, in case of snapshot, which then reduces the overall image resolution.

2.4.5 HSI Image processing
Image processing is a method that is used to get more information and to characterize an image. It
converts the image into digital form and applies various analysis methods in order to get a better
understanding of the image and to extract some useful information that cannot be seen or observed.
Usually, image processing systems treat images as two dimensional signals while applying already
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set signal processing methods to them [49], [50]. Image processing can also be used to manipulate
images, and apply many different operations in order to extract, detect, and distinguish new
information. That however, will allow the user to visualize and present images in different and
unique way [50], [73]. At the hyperspectral processing stage, geometric registration and calibration
might be performed to make it possible to compare this data set with other data sets. Feature
extraction may also be conducted to reduce the dimensionality of data and at the same time to
increase accuracy by increasing the separability of various classes in the image. In this study, the
data is normally divided into 2 classes, positive cancer, and negative cancer, which are referred to
as 0 and 1. At last, the data goes through an interpretation stage depending on different
applications, which means for different needs there are different processing methods to make full
use of the data. As in this work, class recognition is only needed for detection, so the data is used
to identify between classes. More details will be explained in the algorithm sections according to
the type of data and algorithms used, whether the data is supervised or unsupervised.

A) Image Clustering: The clustering of an image, is an advanced recognition of the complex
characterization of an image [71], [73]. It also describes an image from the dataset level, with
certain information required to be able to categorize a certain image or set of images into multiple
classes or clusters, also be described as image mapping. Image clustering can allow editing and
dealing with the dataset as group of classes, which is very useful in many image processing
applications such as feature imaging and image representation [71]. Organization of feature data
is used to classify an image to a certain cluster.

B) Image Classification: Classification of an image creates multiple classes depending on the
data contained in the image, so each class will have specifications to group them together as one
class. Classification also refers to the task of extracting information classes from an image [72],
[73]. The classifier creates a special environment for each dataset in order to classify each data.
Classification is a process of multiple steps of studying the data and creating labels, training, and
testing steps. Classification gets more complex with the size and complexity of the data. There are
two types of classification: supervised and unsupervised [73].
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B-1) supervised classification: A very simple description of a supervised classification is when
the classification is given to a dataset that is labeled based on a key feature, such as the spectral
signatures obtained from training samples, to classify an image [73], [74]. Then the classifier can
create a signature file from the training samples, which is then used by the multivariate
classification to classify the image.
B-2) unsupervised classification: The opposite of supervised classification, unsupervised
classification where classifier is given dataset without labels [73], [75]. The classifier then finds
spectral classes in a multiband image without the any assigned values from the data provider. The
Classification treats unsupervised data by providing access to the tools to create the clusters,
capability to analyze the quality of the clusters, and access to classification tools [75].

2.4.4.1 Examples of classification algorithms:
A) Support Vector Machine (SVM) algorithm for supervised data.
SVM can be described as a classifier that can identify and create a hyperplane that separates
between the different classes [55], [56]. In other words, given labeled training data, the algorithm
outputs an optimal hyperplane which categorizes an examples figure 2.8. This will happen only if
the data is linearly separable. The optimal hyperplane is the best hyperplane that has the maximum
separation distance, as shown in Figure 2.10.

Figure 2.10: Hyperplane separating two classes (LSVM) [55]
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In the case of Linear SVM, the hyperplane an equation is applied to get the optimal hyperplane
with the max margin. The SVM linear classifier relies on a dot product between data point vectors.
if.

Then the classifier is given by:

𝑥

𝑥

𝑓(⃗⃗⃗⃗⃗) = 𝑠𝑖𝑔𝑛( ∑𝑖 𝛼𝑖 𝑦𝑖 𝐾 (⃗⃗⃗⃗⃗⃗⃗
𝑥𝑖, ⃗⃗⃗⃗⃗ + 𝑏)

Equation 2.8[56]

In MATLAB, the classifier that was used to analyze the dataset generates a nonlinear classifier
with a Gaussian kernel function. First, it generates one class of points inside the unit disk in two
dimensions, and another class of points in the annulus from radius 1 to radius 2. Second, it
generates a classifier based on the data with the Gaussian radial basis function kernel. The default
linear classifier is obviously unsuitable for this problem, since the model is circularly symmetric
[57]. Then the classifier will identify the classified with the misclassified points by generating two
sets of 100 points as follows: Generate 100 points uniformly distributed in the unit disk. To do so,
generate a radius r as the square root of a uniform random variable, generate an angle t uniformly
in (0, 2pi ), and put the point at (r cos( t ), r sin( t )), then generate 100 points uniformly distributed
in the annulus. The radius is again proportional to a square root, this time a square root of the
uniform distribution from 1 through 4. Finally, the classifier will compare between both [56], [57].

B) K-means for unsupervised data.
K-means is a learning algorithm that is applied to solve unsupervised data classification problems
[54]. It starts first by choosing number of classes (clusters). The main idea is to define k centers,
one for each cluster. These centers should be placed in a cunning way because of different k center
locations causes different result. So, the better choice is to place them as much as possible far away
from each other [58]. The next step is to take each point belonging to a given data set and associate
it to the nearest center. In this case each class will have one centroid, and the result becomes more
stable with increase iterations Also the more data the classifier is given, the better the centroid
accuracy will be [58], [59]. The equation is given by:
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𝐽(𝑉) = ∑𝑐𝑖=1 ∑𝑐𝑖=1(‖𝑥𝑖 − 𝑣𝑖‖)2

Equation 2.9[58]

where ‘||xi - vj||’ is the Euclidean distance between xi and vj., ‘ci’ is the number of data points
in ith cluster, and ‘c’ is the number of cluster centers.

The process starts by randomly selecting ‘c’ cluster centers, then calculating the distance
between each data point and cluster centers. After that, a data point is assigned to the cluster
center whose distance from the cluster center is the minimum of all the cluster centers. The new
cluster center is then recalculated using:

1

𝑣𝑖 = ( ) ∑𝑐𝑖
𝑗=1 𝑥𝑖
𝑐𝑖

Equation 2.10[59]

where ‘ci’ represents the number of data points in ith cluster.
Then, again distance between each data point and newly obtained cluster centers is recalculated.
Finally, if no data point was reassigned, the calculation loop is stopped. Otherwise, it is repeated
until no changes in the centroid values occur [58].

2.5 Summary
In summary, Hyperspectral imaging is a very useful tool that can be applied in many different
applications. As an imaging system, it can be adopted to be used in almost any application that can
use optical imaging from the army to educational institutes, to hospitals and industries. Image
processing is undeniably important to work with HSI, as the images needs to be analyzed, and
processed. In this work the algorithms that were used, focused on both classification methods for
the supervised and unsupervised data to measure the imaging system abilities to detect the spectral
difference between cancer and normal. The next chapters will provide the different approaches of
using both algorithms, the accuracy and results.
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Chapter 3
3. HSI System Evaluation, and Cellular Imaging
3.1 Introduction
This chapter describes the details of HSI system setup & testing experiment. Prior to
experimentation, the hyperspectral imager was connected to a microscope and calibrated based on
a standard process. Section 3.2 in this chapter provides the experiment applied on breast cancer
tissue sample in order to make sure that the hyperspectral system is ready for the main study of
this thesis. Sections 3.3 to 3.5 are the cellular imaging sections that provides more details about
the main studies and the imaged samples.
The hyperspectral imager was connected to a microscope as shown in Figure 3.1-a. The upright
microscope used in this setup is a Nikon Optiphot-2 (Figure 3.1-b) with a t 12V-100W LL halogen
lamp illumination source. The microscope has a three filters, such as a neutral-density filter, which
were not used in this study. The objective lens that was used to capture all of the images in this
study is CF Achromat P40x.
b

a
Hyperspectral imager
C mount adapter

CF objective lens
HSI control and
display unit
Light source

Nikon Optiphot- 2

Figure 3.1: a- Hyperspectral imaging system setup Davis lab in WVU Cancer Institute. b - Nikon
Optiphot-2
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The Arrow snapshot hyperspectral imaging camera from Rebellion Photonics is capable of two
imaging configurations with two different sets of spectral bands. The configuration that was used
in this study is 443 x 313 pixel resolution in the spatial domain with 31 bands in spectral domain.
The spectral range of this system is within the visible light spectrum between 461nm and 641nm.
The field of view of the hyperspectral camera attached to the microscope with a 40x objective in
its best resolution is 100µm X 80µm, allowing the capture of many images from a single tissue
sample, which averaged 8.0x10-5 cm2 for this study,

3.2 Hyperspectral imaging experiment
This section provides a description of the tissue sample imaging process. The samples are grouped
into three main types:
1. H&E stained of normal and DCIS samples
2. Unstained samples of normal and DCIS tissues
3. In situ and invasive tissue samples of mouse mammary tumor
In the first imaging experiment, the hyperspectral imaging system was applied on 10 samples from
patients that have tested positive for invasive ductal carcinoma breast cancer. Each patient has two
H&E tissue samples marked by WVU Pathologist, Dr. James Coad. The West Virginia University
Institutional Review Board approved this investigation [Protocol 1509816662 (Non-Human
Subject Research)]. A copy of the approval letter can be found in Appendix C. The second imaging
experiment includes set of breast tissue samples taken from the same 10 patients, but without
staining in order to observe the spectral signature of both normal and cancer tissues in an unstained
state. The last imaging experiment is performed on samples taken from mice that have tested
positive for invasive ductal carcinoma (IDC) breast cancer and Ductal Carcinoma in Situ (DCIS).
The West Virginia University Research Compliance Office and Institutional Animal Care and Use
Committee approved the use of animals from which the mammary tissues were rendered [ACUC
Protocol 10-1107]. Each mouse has two H&E tissue samples of IDC and DCIS marked by the
pathologist. This chapter will show a few images of each samples set, with the remaining images
included in Appendix A.
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3.2.1 Preparation methods of the Pathology Samples
This study will apply hyperspectral imaging technology to provide an indication of the spectral
reflectance differences of ductal carcinoma tissue samples. Figure 3.2 shows an example of H&E
stained ductal carcinoma biopsy sample taken from a breast cancer patient.

Figure 3.2: Hyperspectral image of a ductal carcinoma tissue.
In this study, we have collaborated with the Pathology Department at WVU hospital to obtain
breast ductal carcinoma tumor biopsies fixed on pathology slides prepared in three deferent as
follow:
1) The commonly used method in pathology is hematoxylin and eosin (H&E) staining with
glass coverslip shown in Figure 3.3-a.
2) Unstained tumor tissue directly on the slide shown in Figure 3.3-a, and
3) Unstained tumor on a slide with a glass coverslip shown in Figure 3.3-a.
a

c

b

Figure 3.3: The top three images: showing the three methods of preparing the tumor on
the slides, (a) H&E staining, (b) Unstaining, and (c Unstaining with glass coverslip.
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3.2.2 Experiments Result
The main imaging experiment focused on the observations of three preparation methods of
biopsy pathology slides. The spectra for each tissue sample type are shown in Figure 3.4.
a

b

c

Figure 3.4: (a) Reflectance spectra comparison of three tissue preparation methods: H&E stain,
unstained with no cover slip, and unstained with cover slip. (b) Reflectance spectra comparison of
unstained samples (US) and unstained samples with cover slip (USC). (c) Reflectance spectra
comparison of H&E and USC, note that the wavelength axis is the band number between 1 to
31 band and it is ranged from 460nm to 640 nm
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The error bars in Figure 3.4 are used to quantify uncertainty in the graph of based on the sample
population of 50 pixels from each image focused on the same region of interest of the imaged
tissue in order to show a clear spectral separation between the three preparation methods. Therefore
the results of three plots from Figure 3.4-b shows a high degree of similarity in the spectra of the
unstained samples, which means if we move the intensity of one, both will be on top of each
other with no differences. Although the difference in the intensity values is clear enough for the
algorithm that was used for analyzing the images to identify it, any change in the light source will
result in change in the intensity. This result answers the first question posed in this initial study, which
is: How does the glass coverslip affect the spectral value between two identical samples imaged in the
exact same condition? Figure 3.4-c answers the second question, which is: Does the H&E stain
affect the spectral reflectance value between two identical samples imaged in the exact same condition?
The answer to this question is ‘yes,’ and the reason is because the interaction of light with the stain
(absorption and reflection) will result in different spectral reflectance from the unstained samples.
More details will be discussed in the next chapter as a part of main study of this work that is
focusing on the spectral reflectance of the H&E stained as well as the unstained samples of normal,
invasive, and pre-invasive ductal carcinoma breast tissues.

3.3 H&E stained Normal and Ductal Carcinoma samples
In this section, example images from biopsy slides shown from 3 out of 10 patients are displayed
below for both of normal and DCIS tissue, the rest are included in Appendix A. Each sample was
imaged by the hyperspectral imager, the analysis of which that will be discussed in Chapter 4.
Figures 3.5, 3.7, and 3.9 show the H&E stained samples of the normal ducts of the three patients
with a monochromatic HSI example images of different wavelength channels between 460nm and
650nm of the normal tissue images to show that the Arrow camera can produce images with clear
detail of the tissue structure. Figures 3.6, 3.8 and 3.10 also show images of both H&E stained
samples of the DCIS tissues of the three patients as well as the HSI images of the chosen
wavelength channels within the same spectral range.
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Figure 3. 5: (a) Visible image of H&E-stained normal
duct tissue from Patient 1. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.6: (a) Visible image of tissue sample
containing ductal carcinoma from Patient 1. Region
inside red box a selected for hyperspectral imaging. (b)
Hyperspectral images of region highlighted in (a) for
select wavelengths ranging from 460-650nm.
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Figure 3.7: (a) Visible image of H&E-stained normal
duct tissue from Patient 2. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.8: (a) Visible image of tissue sample
containing ductal carcinoma from Patient 2. Region
inside red box a selected for hyperspectral imaging. (b)
Hyperspectral images of region highlighted in (a) for
select wavelengths ranging from 460-650nm.
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Figure 3.9: (a) Visible image of H&E-stained normal
duct tissue from Patient 3. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.10: (a) Visible image of tissue sample
containing ductal carcinoma from Patient 3. Region
inside red box a selected for hyperspectral imaging. (b)
Hyperspectral images of region highlighted in (a) for
select wavelengths ranging from 460-650nm.
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In this section, a visible images of H&E-stained normal duct, and DCIS tissues were shown from
the three example patients, as well as the regions that were selected for hyperspectral imaging for
select wavelengths ranging from 460-650nm. The next section will provide the images of the
unstained tissue samples that was imaged and evaluated in this study.

50

3.4 Unstained Normal and Ductal Carcinoma samples
In this section also, using the same methodology described in Section 3.3, example images from 3
out of 10 patients are displayed below of both biopsy samples of normal and DCIS tissues, the rest
are included in the appendix. However, the samples are unstained in this case. Each sample was
imaged by the hyperspectral imager, the analysis of which that will be discussed in Chapter 4.

Figure 3.11: (a) Visible image of unstained normal
duct tissue from Patient 1. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.12: (a) Visible image of unstained tissue
sample containing ductal carcinoma from Patient 1.
Region inside red box a selected for hyperspectral
imaging. (b) Hyperspectral images of region
highlighted in (a) for select wavelengths ranging from
460-650nm.
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30µm

Figure 3.13: (a) Visible image of unstained normal
duct tissue from Patient 2. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.14: (a) Visible image of unstained tissue
sample containing ductal carcinoma from Patient 2.
Region inside red box a selected for hyperspectral
imaging. (b) Hyperspectral images of region
highlighted in (a) for select wavelengths ranging from
460-650nm.
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30µm

Figure 3.15: (a) Visible image of unstained normal
duct tissue from Patient 3. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.16: (a) Visible image of unstained tissue
sample containing ductal carcinoma from Patient 3.
Region inside red box a selected for hyperspectral
imaging. (b) Hyperspectral images of region
highlighted in (a) for select wavelengths ranging from
460-650nm.
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In this section, a visible images of unstained normal duct, and DCIS tissues were shown from the
three example patients, as well as the regions that were selected for hyperspectral imaging for
select wavelengths ranging from 460-650nm. Figures 3.11, 3.13, and 3.15 show the unstained
samples of the normal ducts of the three patients with a monochromatic HSI example images of
different wavelength channels between 460nm and 650nm of the normal tissue images to show
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that the Arrow camera can produce images with clear detail of the tissue structure. Figures 3.12,
3.14 and 3.16 also show images of both unstained samples of the DCIS tissues of the three patients
as well as the HSI images of the chosen wavelength channels within the same spectral range. The
next section will provide the images of the unstained tissue samples that was imaged and evaluated
in this study

3.5 H&E Stained In Situ and Invasive Ductal Carcinoma
In this section, the methodology that was used for human breast tissue the previous sections is
applied on 4 tissue samples from mice that have tested positive for invasive ductal carcinoma
(IDC) breast cancer and Ductal Carcinoma in Situ (DCIS). Each mouse sample has two H&E
marked pathology samples of IDC and DCIS tissue. Each sample was imaged by the hyperspectral
imager, the analysis of which that will be discussed in Chapter 4.
Figures 3.17, 3.19, and 3.21 show the H&E stained samples of the DCIS of the three mice with a
monochromatic HSI example images of different wavelength channels between 460nm and 650nm
of the normal tissue images to show that the Arrow camera can produce images with clear detail
of the tissue structure. Figures 3.18, 3.20 and 3.22 also show images of both H&E stained samples
of the IDC tissues of the three mice as well as the HSI images of the chosen wavelength channels
within the same spectral range.
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Figure 3.17: (a) Visible image of H&E-stained DCIS
tissue from mouse 1. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.18: (a) Visible image of H&E-stained IDC
tissue from mouse 1. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.19: Visible image of H&E-stained DCIS
tissue from mouse 2. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.20: (a) Visible image of H&E-stained IDC
tissue from mouse 2. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.21: (a) Visible image of H&E-stained DCIS
tissue from mouse 2. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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Figure 3.22: (a) Visible image of H&E-stained IDC
tissue from mouse 3. Region inside red box was
selected for hyperspectral imaging. (b) Hyperspectral
images of region highlighted in (a) for select
wavelengths ranging from 460-650nm.
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3.6 Summary
This chapter provides the first, and second tasks of this study that includes the HSI system setup,
testing, and the cellular imaging. The first task includes a set of two experiments in order to have
a clear image of the spectrum depends on our light source, as well as learning how the hypercube
is built according to the hyperspectral imager that is used in this study. Two main experiments are
done after the system calibration. These experiments are called: HSI leaves experiment, and three
pathology slides preparation method. The first experiment shows the capability of the HSI system
to identify, and differentiate between leaves, and their growing stages in the season depends on
the spectral reflectance of the sun light. The second experiment focused on finding a spectral
relationship between three different methods of preparing the biopsy slides by the pathologist,
The second task is the cellular imaging, which include includes three case studies provided in this
work. Each section included three picked examples from the whole group of the imaged samples.
The three imaged groups are as follow: H&E stained of normal and DCIS samples, unstained
samples of normal and DCIS tissues, and finally in situ and invasive of mice mammary tumor. The
aim of this chapter is to provide a set of examples to show how normal breast, DCIS, and IDC
tissues would look like as a hyperspectral image, and as an image seen by pathologist under the
microscope as well as the H&E stained and unstained samples. This chapter has also provided the
hyperspectral images that includes the Region of Interest (ROI) that was marked by the pathologist
to show the exact location that needed to be imaged and analyzed using the hyperspectral imager.
The overall goal of this chapter is to prepare a set of hyperspectral images of the (ROI) to be
analyzed and processed using two different algorithms for semi automation detection that will be
shown in chapter 4.
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Chapter 4
4. Image Evaluation
4.1 Introduction
This chapter discusses image analysis and evaluation. The large amount of data contained in the
three-dimensional hyperspectral data cube was evaluated in multiple steps. All images were
initially manually marked by a pathologist for the purpose of providing ground truth description
of the tissue samples showing evidence of cancer. This is an important step for training the auto
detection algorithm, as well as evaluating the accuracy on tissue samples not included in the
training set. All marked areas on the samples were identified by the pathologist to possess a high
density of tumor tissue within the designated area. Image processing techniques were applied to
look at the regions of interest identified by the pathologist and ultimately determine the spectral
reflectance of tissues in these regions over the visible light wavelength spectrum. The image
processing and HSI toolboxes contained in both MATLAB and Waikato Environment for
Knowledge Analysis (WEKA) were used in image processing. WEKA is a collection of machine
learning algorithms for data mining tasks that were developed at university of Waikato New
Zealand). In this work, the algorithms are used to learn the about the nature of the hyperspectral
data in order to understand the spectral reflectance value and how it can be used to differentiate
between different regions in the tissue samples. The first section of this chapter is focused on
analyzing the manually picked regions of the hyperspectral images, then plotting the spectral
reflectance spectrum to compare between the tissues. Finally, spectral reflectance color filtering is
applied to the images to evaluate the spectral response of the various regions and types of tissue
visible in the images. In the latter sections of this chapter, a semi-auto algorithm was applied to
both the supervised, and unsupervised (i.e. labeled, and unlabeled) hyperspectral data sets.
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4.2 Spectral reflectance determination of manually marked cancer
tissue
Because ductal carcinoma normally starts spreading from the duct, 4 square regions were randomly
picked around each normal duct and in high density areas of the ductal carcinoma samples known
to contain tumorous tissue. The results of hyperspectral images from each patient will consist of:
1) A comparison of spectral reflectance measurements from each area, and the average with
error and standard deviation computed for 10 measurements from each of 4 separate
regions per ample type.
2) Images with spectral reflectance color filtering applied on the spectral band that shows the
highest degree of wavelength separation between normal tissue and ductal carcinoma. The
spectral reflectance color filtering is presented as a color map that is representative of the
spectral reflectance value.

4.2.1. Hyperspectral imaging of H&E-stained normal and DCIS tissue samples from
patients 1-3
Spectral reflectance plots of the 4 marked areas of the H&E tissue samples of patient 1 from are
shown in Figure 4.1.
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Figure 4.1: Spectral reflectance of each of the 4 marked areas of the 550nm spectral channel from
top left to bottom right.
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Figure 4.2: Average response showing spectral reflectance of the cancer and normal tissues.
The error bars in Figure 4.2 are used to quantify uncertainty in the graph based on an average of
10 measurements taken from each of the four marked region of interest in Figure 4.1 for both
normal and cancer tissue. This was done in order to show a clear separation between both tissues
at 550nm. This method is also applied on all data shown in the following sections 4.2.2, and 4.2.3.
The Spectral Reflectance Color Filtering (SRCF) method is applied to the hyperspectral images to
visualize the difference in the spectral reflectance between tissue types present in one biopsy
sample, as well as between tissues in different sample types (normal and DCIS). The scale in
Figure 4.3 shows the normalized spectral reflectance intensity values for the normal and DCIS
samples from Patient 1. The high-intensity regions, denoted by the red/orange color, represents the
location of the milk ducts as marked by the pathologist. The lower intensity regions denoted by
the dark blue color, which are the regions of interest for this research effort, represent normal and
DCIS tissues surrounding the ducts. It can be seen that both normal and DCIS tissue have similar
low SCRF values, which corresponds to the spectral plot shown in Figure 4.2. This small
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difference makes it challenging to perform accurate detection by just comparing the difference
between ‘light’ and ‘dark’ blue in the SCRF images. Additional image analysis must be applied to
achieve accurate cancer detection. To further illustrate this, results from the H&E-stained samples
from two additional patients are shown in Figures 4.4-4.7.

Figure 4.3: SRCF of both normal duct (Left), and ductal carcinoma (Right), and the spectral
reflectance normalized scale.
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The spectral reflectance of the 4 marked areas of the H&E-stained normal and DCIS tissue
samples from Patient 2 are shown in Figure 4.4 & 4.5, with the SCRF results shown in Figure 4.6
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Figure 4.4: Spectral reflectance of each of the 4 marked areas of the spectral channel 550nm
from top left to bottom right.
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Figure 4.5: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.6: SRCF of both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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The spectral reflectance plots for the 4 marked areas of the H&E-stained normal and DCIS tissue
samples from Patient 3 are shown in Figures 4.7 & 4.8, with the SCRF results shown in Figure
4.9.
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Figure 4.7: Spectral reflectance of each of the 4 marked areas of the spectral channel 550nm
from top left to bottom right.

72

Figure 4.8: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.9: SRCF of both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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4.2.2: Hyperspectral imaging of unstained normal and DCIS tissue samples of from
Patient 1
The spectral reflectance plots of 4 marked areas of unstained normal and DCIS tissue samples
from Patient 1 are shown in Figure 4.10 & 4.11, with the corresponding SCRF images shown in
Figure 4.12.
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Figure 4.10: Spectral reflectance of each of the 4 marked areas of the spectral channel 550nm
from top left to bottom right.
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Figure 4.11: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.12: SRCF of both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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4.2.3: Hyperspectral imaging of H&E-stained DCIS and IDC tissues from Mice 1-3
The spectral reflectance plots of 4 marked areas H&E-stained DCIS and IDC tissue samples
from Mouse 1 are shown in Figures 4.13 & 4.14, with the corresponding SCRF images shown in
Figure 4.15.
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Figure 4.13: Spectral reflectance of each of the 4 marked areas of the spectral channel 500nm
from top left to bottom right.
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Figure 4.14: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.15: SRCF of both DCIS (Left), and IDC (Right), and the RICF scale.
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The spectral reflectance plots of 4 marked areas H&E-stained DCIS and IDC tissue samples
from Mouse 2 are shown in Figures 4.16 & 4.17, with the corresponding SCRF images shown in
Figure 4.18.
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Figure 4.16: Spectral reflectance of each of the 4 marked areas of the spectral channel 500nm
from top left to bottom right.
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Figure 4.17: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.18: SRCF of both DCIS (Left), and IDC (Right), and the RICF scale.
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The spectral reflectance plots of 4 marked areas H&E-stained DCIS and IDC tissue samples
from Mouse 3 are shown in Figures 4.19 & 4.20, with the corresponding SCRF images
shown in Figure 4.21.
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Figure 4.19: Spectral reflectance of each of the 4 marked areas of the spectral channel 500nm
from top left to bottom right.
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Figure 4.20: Average response clearly showing spectral reflectance of the cancer and normal
tissues.

Figure 4.21: Spectral reflectance of each of the 4 marked areas of the spectral channel 500nm
from top left to bottom right.
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4.3 Selection of image data for training cancer detection
algorithm
4.3.1 Supervised data for Support Vector Machine (SVM) classifiers using a
Gaussian algorithm on human-female H&E stained breast tissue
In this section, the method used to process and analyze images using the HSI toolboxes contained
in both software MATLAB and. WEKA is described. The SVM methods were applied on
supervised (labeled) data, and a K-means algorithm were applied on the unsupervised (unlabeled)
data. As described in Chapter 2, a Gaussian SVM is applied on the data set after preparing the data
for classification. The data is transferred into 1D and then labeled with two classes, 0 and 1, for
the system to be able to train and test for testing the classifier accuracy. This classifier is applied
for the purpose of detection cancer tissue, so the answer that is required is either positive cancer
or negative cancer, allowing the data to be transferred into 1D for simplicity. Table 4.1, shows the
classifier accuracy for each patient, and the diagrams follow that describe the prediction and
classifier accuracy of the tested model for detection. More details are given in the discussion
following the diagrams.

Table 4.1: SVM algorithm on 10 patients
Patient #

Accuracy

Patient #

Accuracy

1

91.0%

6

98.7%

2

90.2%

7

91.7%

3

88.5%

8

85.0%

4

90.4%

9

87.8%

5

99.1%

10

79.3%

Average Accuracy:

90.17%
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Classes:
 0
 1

b

a

c

Figure 4.22: a- Scatter plot of the SVM algorithm, b- ROC curve of the prediction, c- Confusion matrix
of the predicted model.
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After applying the trained algorithm on the samples from the patients, the following step is to apply
the trained algorithm on the testing data for prediction, and detection accuracy. Figure 4.22-a
shows the results given by a scatter plot of the values for both classes, followed by the ROC curve
showing the area under the curve= 0.89 in Figure 4.22-b which is supported by the confusion
matrix in Figure 4.22-c, which shows the confusion matrix of the tested model showing a true
positive rates of 92% and 84%, false negative rates of 8% and 16%.

4.3.2 Unsupervised data for K-means algorithm on human- female H&E stained
breast tissue
The K-means algorithm described in Chapter 2 was applied to unsupervised (i.e. unlabeled) data.
The user chooses the number of classes, which is 2 for this study (cancer, and non-cancer), and
then the algorithm picks the best centroid for each class. The class centroids changes each time the
algorithm runs until the program stops, i.e. when the numbers of each class do not change, and
each centroid is considered the best pick. Table 4.2 shows the results of applying K-means
separately on each set of data from 9 out of 10 patients for training, iterating to find the two best
values of centroids, and finally, using the known labels of cancer and non-cancer to measure the
accuracy of each run. The last step is to run the K-means trained algorithm on the 10th patient for
testing the cancer detection scheme in order to determine if the classifier can identify and detect
both classes, and then compare the detected results with the ground-truth pathologist diagnosis in
order to support the algorithm accuracy. The detection results will be shown in the Section 4.5.
Table 4.2 also shows the prediction accuracy of the algorithm by applying the labels on the data
by using the centroids that the trained algorithm created.
Table 4.2: K-Means algorithm results from tissues obtained from Patients 1-9.
Patient #

Centroid1

Centroid2

Accuracy

Patient#

Centroid1

Centroid2

Accuracy

1

0.251

0.072

85.38%

6

0.287

0.066

98.34%

2

0.182

0.062

82.87%

7

0.270

0.096

80.59%

3

0.209

0.088

79.41%

8

0.223

0.099

82.22%

4

0.170

0.070

87.38%

9

0.265

0.075

87.84%

5

0.296

0.046

98.5%

1-9

0.207

0.091

80.27%

Average Accuracy

85.47%
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4.3.3 Supervised data for Support Vector Machine SVM classifiers using a
Gaussian algorithm on unstained human- female breast tissue samples.
The same method applied in section 4.3.1 to the hyperspectral images from the H&E stained
samples was then applied to the unstained samples. On the sample, 1600-pixel samples were tested
using the SVM algorithm. Every pixel is labeled for system training, which is followed by testing.
10-fold cross validation was applied for accurate results. Table 4.3 presents the accuracy predicted
detection of the trained algorithm, and the diagrams follow that describes the prediction and
classifier accuracy of the tested modal for detection. More details are given in the discussion
follows the diagrams
Table 4.3: SVM algorithm on unstained sample

Patient 1-10

Accuracy

AVG

94.4%

Classes:
 0
 1

a

b
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c

Figure 4.23: a- Scatter plot of the SVM algorithm, b- ROC curve of the prediction, cConfusion matrix of the predicted model.
After analyzing the data by training the algorithm on the samples from patients, the following step
is to apply the trained algorithm on the testing data for prediction and detection accuracy. Figure
4.23-a shows the results given by a scatter plot of both classes with the prediction, followed by the
ROC curve showing the area under the curve= 0.95 in Figure 4.23-b. Finally 4.23-c shows the
confusion matrix of the tested model showing a true positive rates of 97% and 92%, false negative
rates of 8% and 3%.

4.3.4 Unsupervised data for K-means algorithm on unstained human- female
breast samples.
The same K-means algorithm method that was applied in section 4.3.2 on the stained samples was
applied and ran on the unstained samples on the average data from the patients for training to create
2 centroids as seen in Table 4.4.
Table 4.4: K-means results from unstained sample images.
Patient#

Centroid1

Centroid2

Accuracy

AVG

0.208

0.085

93.66%
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As Table 4.4 shows the result of applying the K-means algorithm on the data that was extracted
from the unstained samples, the trained algorithm created two centroids one for each class as
explained on the previous section. The trained algorithm then applied on the testing data for
detection to get an accuracy of 93.66%.

4.3.5 Supervised data for Support Vector Machine SVM classifiers using a
Gaussian algorithm on mice models with positive DCIS, and IDC
The same SVM method that was applied on sections 4.3.1 and 4.3.3 to analyze the H&E-stained
and unstained tissue samples of the human patients was applied to the unstained mouse tissue
samples. The predicted classes that are labeled 0, and 1, representing the presence of DCIS IDC
respectively. Again, 1600-pixel samples were tested using the SVM algorithm, with every pixel
labeled for system training then testing. 10-fold cross validation was applied for accurate results:
Table 4.5 presents the accuracy of the detection using the trained algorithm, and the diagrams that
follow describe the prediction and classifier accuracy of the tested modal for detection. More
details are given in the discussion following the diagrams
Table 4.5: SVM algorithm on H&E mice samples

Mouse#

Accuracy

Mouse #

Accuracy

1

90.9%

3

92.8%

2

94.6%

4

84.2%

Average Accuracy:

90.17%
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c
Figure 4.24: a- Scatter plot of the SVM algorithm, b- ROC curve of the prediction, cConfusion matrix of the predicted model.
After analyzing the data by training the algorithm on the samples from mice models, the following
step is to apply the trained algorithm on the testing data for prediction, and detection accuracy.
Figure 4.24-a shows the results given by a scatter plot of both classes with the prediction, followed
by the ROC curve showing the area under the curve= 0.92 in Figure 4.24-b. Finally 4.24-c shows
the confusion matrix of the tested model showing a true positive rates of 99% and 83%, false
negative rates of 1% and 17%.
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4.3.6 Unsupervised data for K-means algorithm on mice models with positive
DCIS and IDC
The K-means algorithm was ran on the unstained samples to create 2 centroids, as seen in Table
4.2. The K-means algorithm method described in Section 4.3.2 was applied to the stained mice
samples. Table 4.6 shows the results of applying K-means separately on each set of data from 3
out of 4 mice modals for training and run to create two best values of centroids and finally, use the
labels to measure the accuracy of each run. The last step is to run the trained K-means algorithm
on the 4th mouse for detection in order to determine if the classifier can identify and detect both
classes, and then compare the detected results with the ground truth pathologist diagnosis in order
to support the algorithm accuracy. The detection results will be shown in the next section 4.5.
Table 4.6 also shows the prediction accuracy of the algorithm by applying the labels on the data
by using the centroids that the trained algorithm created.
Table 4.6: K-means algorithm on Mice samples
Patient #

Centroid1

Centroid2

Accuracy

1

0.168

0.050

89.5%

2

0.185

0.047

93.47%

3

0.174

0.039

88.84%

1-3

0.149

0.056

83.03%

4.5 Applying trained algorithms for semi-automated
detection
This section provides a description of the effectiveness of the application of the trained detection
algorithm for the detection of normal, DCIS, and IDC in random tissue samples from human and
mice models that were not used in the previous testing or training sample sets. An overview of thie
application, from image acquisition, training, and application of the detection scheme is shown in
Figure 4.25.
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Figure 4.25: hyperspectral imaging, training, and detection.

4.5.1 Cancer detection in human sample
The trained algorithms were applied samples from patient that was diagnosed with DCIS. The
samples were marked, and prepared by a pathologist, and then images were captured and processed
by the hyperspectral imaging system. Figure 4.26 shows the steps taken to provide a ground truth
that the trained algorithms were successfully able to match the pathologist’s performance at
detecting difference between normal and cancer. After the samples were prepared, Dr. James Coad
the Vice-Chair of WVU Pathology diagnosed and marked regions of interest on the samples within
the entire region of the tissue on the slide. Figure 4.26 also shows the samples from the 9 patients
that were used in training the K-means algorithm as well as the 10th patient data used for detection.

90

10 patients

Figure 4.26: Dr. James Coad marking the ROI to compare the detection results of the algorithm
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The result of training the K-means algorithm on the data that was extracted from the first 9 patients,
then the trained algorithm was applied on the untrained data that was extracted from the 10th
patient. The algorithm and successfully detected normal and cancer tissue as shown in Figure 4.27.
In this figure, the blue boxes indicate the areas containing cancer marked by the pathologist, and
the red and blue shaded regions are the regions with cancer identified by the hyperspectral
detection algorithm.

Figure 4.27: The blue boxes indicates the areas marked by the pathologist, the shaded
areas shows the detection of the K-means algorithm detecting cancer tissues (Red), and
normal tissues (blue) on the spectral channel 550nm.

4.5.2 Mice samples detection
The method described in Section 4.5.1 was repeated in on the mouse tissue samples. Three out of
four samples were used for training and the 4th sample was used for testing and detection. The
trained algorithms were applied on random tissue samples from mice that were diagnosed with
both IDC, and DCIS. The samples were marked and diagnosed by Dr. Majed Pharaon from WVU
pathology. Images were then captured and processed by the hyperspectral imaging system. Figure
4.28 shows that the trained algorithm were successfully able to detect a spectral difference between
IDC and DCIS with an accuracy of 90%.
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Figure 4.28: The blue boxes indicates the areas marked by the pathologist, the shaded
areas shows the detection of the K-means algorithm detecting IDC (Red), and DCIS
(blue) on the spectral channel 500nm.

4.6 Results & Summary
Image evaluation and analysis were applied on three sample groups in order to develop semiautomated methods to identify the spectral differences between:
1) normal and DCIS cancer tissues, and
2) DCIS and IDS tissues, which indicate different stages of breast cancer
The HSI system was used to image and analyze breast biopsy tissue from human patients, as well
as mammary tumor tissue extracted from mouse models. The biopsy tissues were fixed and stained
on pathology paraffin-embedded slides at the WVU Health Sciences Center. Each slide with either
normal, invasive, or in situ ductal carcinoma was marked by the pathologist. In this study, two
samples, consisting of normal and DCIS tissue, were obtained from each of 10 patients. There are
two tissue samples from each mouse as well, but one is invasive and the other one is in situ ductal
carcinoma. Each slide was imaged by the hyperspectral system, and a manual region of interest
was chosen for testing the spectral differences, between normal, DCIS, and invasive and DCIS
tissues. For more accurate results, an algorithm was built to choose random pixels from both
regions of interest. The region of interest spectrum for chosen pixels within the images of the
normal, invasive, and DCIS tissues shows spectral separation between both tissues, which at
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~550nm in most cases. This wavelength was chosen choose for testing the spectral reflectance by
color filtering. The spectral reflectance color filtering results show that the spectral reflectance
values clearly identifies, and separates normal, and DCIS in the spectrum, and also a slight
difference between invasive and DCIS, as DCIS tissue has higher spectral reflectance value within
the chosen wavelength band.
In the second part, two image processing algorithms have been applied on the hyperspectral data of
the tissue sample images for training the system, and then testing whether or not the system is capable
of detecting the spectral difference. Each algorithm has a different approach. The first algorithm was
a supervised Support Vector Machine (SVM) algorithm, where the algorithm is trained on image data
labeled by a pathologist. The system then is trained according to the provided labels. Finally, the
system will randomly pick data that has not been trained and test it. The detection of normal, and
DCIS in human samples result reached a true positive rates of 97% and 92%, false negative rates of
8% and 3%, while, the detection of IDC, and DCIS in mice result reached a true positive rates of
99% and 83%, false negative rates of 1% and 17%. The second algorithm, K-means, was applied
on unsupervised data, where the system trained itself to divide the data into two classes depending
on the Euclidean distance. After the system classified two classes, it creates two centroids, one for
each class. The value of each centroid keeps on changing while the algorithm is running until a
minimum (or zero) change in distance is reached. Finally, labels were used to measure the
algorithm accuracy. In the case of H&E-stained samples, the trained algorithm was applied on
untrained data for testing and detection, and the results were compared with the pathologist
diagnoses to show that the trained algorithm can differentiate between normal and cancer tissue,
as well as between different stages of cancer In summary, the hyperspectral imager system shows
a potential for moving forward to create a baseline in order to make this system ready for clinical
applications.

94

5. Conclusion and Future Work
Hyperspectral Imaging (HSI) is a sophisticated non-invasive optical imaging modality that has the
potential to be applied toward medical imaging research and clinical practice. From imaging labs,
to National Institute of Health (NIH), to cancer institutes, hyperspectral imaging has been an
optical imaging tool that is used for providing spectral information, which can help in material
detection. Hyperspectral imaging brings a new hope in breast cancer research and diagnostic
imaging. Specifically, this research effort introduces a new tool that can help in breast cancer
detection by providing pathologists with a tool that can potentially make their diagnosis process
of ductal carcinoma under the microscope easier and more efficient. This work is a collaboration
between the Lane Dept. of Computer Science and Electrical Engineering, the WVU Pathology
Department, and the WVU Medicine Mary Babb Randolph Cancer Center.

Figure 5.1: Concept diagram of how HSI can aid the pathologist in cancer detection and diagnosis.
Pictures (left to right): pathology tech [60], hyperspectral imager system at WVU, image processing DCIS
samples, pathologist diagnosing a sample on a monitor [59].

The overall scope of the work is to image samples of breast cancer tissues from different patients
in order to show the ability of the hyperspectral system to detect spectral differences between
normal and breast cancer tissues, as well as early and late stages of cancer, which will also effect
the treatment decision. Figure (5.1), shows how hyperspectral imaging is introduced to pathology
95

to be a bridge connects between pathology assistant or pathology tech, who prepare the samples
for diagnosis, and the pathologist to make a diagnosis decision.
The HSI technology was applied on three case studies as follow:
1) H&E stained tissue samples of normal and DCIS from breast cancer patients
2) Unstained tissue samples of normal and DCIS from breast cancer patients
3) H&E stained tissue samples of the DCIS, and IDC of mice models.
Each of the three cases represents two tissue samples from each patient or mouse model. Each
sample was imaged by the hyperspectral system and a manual region of interest was chosen for
testing. The system results showed clear spectral reflectance separation between each of the two
tissues that was tested in the three case studies, which are the H&E stained normal and Ductal
carcinoma tissues. The unstained normal and ductal carcinoma tissues. And lastly, invasive and in
situ mice mammary tumor to show spectral reflectance between breast cancer stages as shown in
Figure (5.2).

Figure 5.2): left to right, human normal and DCIS H&E tissues, human normal and DCIS
unstained tissues, mice DCIS and IDC H&E tissues.
In some cases, the results that showed the largest separation appeared in the 550nm wavelength
channel of the snapshot hyperspectral camera, making it a good wavelength to pick for testing the
spectral reflectance color filtering method. The spectral reflectance color filtering method was
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applied on the 550nm channel, which reflects a scale of colors depends on the spectral reflectance
value. The results show a slight difference between normal and cancer tissues, while invasive and
DCIS as DCIS tissue has higher spectral reflectance value for the chosen wavelength channel. In
the hyperspectral image analysis chapter, two image processing algorithms, SVM and K-means,
show the potential of building a semi-atomized system that can identify and sort between the samples
and show the degree of the spectral reflectance difference. Figure (5.3), shows a diagram to explain
the steps of applying the hyperspectral imaging system starting with imaging the samples, to
analyzing the images, to train the algorithms on the data, and finally applying the trained algorithms
for detection.

Figure 5.3: hyperspectral imaging, training, and detection.

The detection result reached the highest accuracy of 94.6% with an average accuracy of 90.17% by
using the supervised SVM algorithm as detection can be seen in Figure 5.4. The second algorithm K-
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means, was applied on unsupervised data, where the system trained itself to divide the data into two
classes depending on the Euclidean distance.

Figure 5.4: an example of applying SVM trained algorithm on a random samples to detect normal
and breast cancer.
Finally, ground truth labeling was used to measure the algorithm accuracy. The highest accuracy of
this algorithm was 93.47%, where the average accuracy was 88.71%, and applying the algorithm on
the whole data joined together resulted in a higher accuracy than the average of 76.01%.

Future Work
The future work that this project is moving toward will be taking two separate paths. The first one
is to continue testing the hyperspectral system on normal, Ductal Carcinoma in Situ (DCIS), and
invasive pathology samples but in larger number, which means the patient sample group will be
expanded. In addition, for more accurate results as well as building a spectral library,
approximately pure samples are more desired. Working with pathology, normal breast tissues will
be acquired from the patient, which can be considered negative cancer in pathology report. The
second path, would be a new cooperation with the animal facility and imaging facility by building
a new animal study. The study plan includes detaching the hyperspectral camera from the
microscope and using it as a regular camera and take pictures of whole mice models with breast
cancer as shown in Figure (5.1), focusing on the breast tissues.
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b

a

c

d

Figure 5.5: a- a prototype of hyperspectral camera used to image the outer breast tissue (skin) of
breast cancer mice models. b- the hyperspectral imaging system, c- WVU Erma Byrd Biomedical
Research Center, d- new hyperspectral camera model of imec.

In addition, a new hyper4spectral imager could be used, as seen in Figure (5.5). The new camera
should have more capabilities to capture near IR and IR to be able to go deeper in the tissues in
addition to the visible spectrum. This will open a new prospective and expand the research to
include a variety of research ideas with a potential of clinical applications such as directly imaging
the breast cancer mice modals without the need of imaging the biopsy tissues under the
microscope, which may lead to a new optical diagnostic imaging system.
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Appendix A
Images of H and E Stained normal and DCIS samples with the manually
picked spectral reflectance regions:
A-1: patient 1

H&E stained sample of normal duct (Left), HSI (Right)

H&E stained sample of ductal Carcinoma (Left), HSI (Right)
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A-2: Patient 2

H&E stained sample of normal duct (Left), HSI (Right)

H&E stained sample of ductal Carcinoma (Left), HSI (Right)
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A-3: Patient 3

H&E stained sample of normal duct (Left), HSI (Right)

H&E stained sample of ductal Carcinoma (Left), HSI (Right)
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A-4: Patient 4

50µm

H&E stained sample of normal duct (Left), HSI (Right)

100µm

H&E stained sample of ductal Carcinoma (Left), HSI (Right)
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Spectral Reflectance of the 4 marked areas:

Spectral reflectance of each of the 4 areas from top left to bottom right.

115

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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A-5: Patient 5

5µm

50µm

H&E stained sample of normal duct (Left), HSI (Right)

5µm

100µm

H&E stained sample of normal duct (Left), HSI (Right)

117

Spectral Reflectance of the 4 marked areas:

Spectral reflectance of each of the 4 areas from top left to bottom right.
118

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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A-6: Patient 6

20µm

5µm

H&E stained sample of normal duct (Left), HSI (Right)

200µm

5µm

H&E stained sample of ductal carcinoma (Left), HSI (Right)

120

Spectral Reflectance of the 4 marked areas:

spectral reflectance of each of the 4 areas from top left to bottom right.
121

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.
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Patient 7:

5µm

H&E stained sample of normal duct (Left), HSI (Right)

5µm

100µm

H&E stained sample of ductal carcinoma (Left), HSI (Right)

123

Spectral Reflectance of the 4 marked areas:

:spectral reflectance of each of the 4 areas from top left to bottom right.
124

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.

125

A-8: Patient 8

5µm

20µm

H&E stained sample of normal duct (Left), HSI (Right)

5µm

100µm

H&E stained sample of ductal carcinoma (Left), HSI (Right)
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Spectral Reflectance of the 4 marked areas:

Spectral reflectance of each of the 4 areas from top left to bottom right.

127

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

: SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.

128

A-10 Patient 10

50µm

H&E stained sample of normal duct (Left), HSI (Right)
:

5µm

100µm

H&E stained sample of ductal carcinoma (Left), HSI (Right)

129

Spectral Reflectance of the 4 marked areas:

spectral reflectance of each of the 4 areas from top left to bottom right.
130

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both normal duct (Left), and ductal carcinoma (Right), and the RICF scale.

131

A-11: Mouse 4

5µm

100µm

H&E stained sample of normal duct (Left), HSI (Right)

100µm

5µm

H&E stained sample of ductal Carcinoma (Left), HSI (Right)

132

Spectral Reflectance of the 4 marked areas:

spectral reflectance of each of the 4 areas from top left to bottom right.
133

Average spectral reflectance of the 4 areas with standard deviation applied.

Apply Spectral Reflectance Color Filtering (SRCF) method.
SRCF method is applied on the samples to visualize the difference in the spectral reflectance
between both samples where the dark blue reflects the lowest reflectance intensity value

SRCF on both DCIS (Left), and IDC (Right), and the RICF scale.
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Appendix B
Weka Software for SVM data detiction:
Key_D
ataset

Key_
Run

Key_
Fold

Key_Scheme

test4

1

weka.classifiers.fun
1 ctions.LibSVM

test4

1

weka.classifiers.fun
2 ctions.LibSVM

test4

1

weka.classifiers.fun
3 ctions.LibSVM

1

weka.classifiers.fun
4 ctions.LibSVM

test4

1

weka.classifiers.fun
5 ctions.LibSVM

test4

1

weka.classifiers.fun
6 ctions.LibSVM

test4

Key_Scheme_options
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
'-S 0 -K 2 -D 3 -G 0.0 -R 0.0 -N
0.5 -M 40.0 -C 1.0 -E 0.001 -P
0.1 -model
C:\\Users\\yasser\\Downloa
ds -seed 1'
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Key_Scheme_
version_ID

Date_
time

14172

2.02E
+07

14172

2.02E
+07

14172

2.02E
+07

14172

2.02E
+07

14172

2.02E
+07

14172

2.02E
+07

Number_of_traini
ng_instances

Percent_u
nclassified
0
0
0
0
0
0

Number_of_testi
ng_instances

Number_c
orrect

Number_i
ncorrect

Number_
unclassifi
ed

Percent_i
ncorrect

Root_relative_
squared_error

Percent
_correct
61.5384
6
53.8461
5
61.5384
6
61.5384
6
58.3333
3
75
SF_prior
_entrop
y

123.9455

13.0135

5370

135.7755

13.0135

6444

123.9455

13.0135

5370

123.9455

13.0135

5370

129.0994
100

12
12

5370
3222

111

13

8

5

0

111

13

7

6

0

111

13

8

5

0

111

13

8

5

0

5
3

0
0

112
12
7
112
12
9
Kappa_ Mean_abs Root_mean Relative_a
statisti olute_erro _squared_er bsolute_er
c
r
ror
ror
0.2696
63
0.384615
0.620174
76.87075
0.1333
33
0.461538
0.679366
92.2449
0.2696
63
0.384615
0.620174
76.87075
0.1975
31
0.384615
0.620174
76.87075
0.1666
67
0.416667
0.645497
83.33333
0.5
0.25
0.5
50
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38.46154
46.15385
38.46154
38.46154
41.66667
25
SF_sche
me_ent
ropy
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Appendix C
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